Toxoplasmosis in adult patients with haematologic malignancy: Seroprevalence of anti-Toxoplasma antibodies and molecular diagnosis
Shaw, T., El-Taweel, H., Gammal, M., Khali, S., Ibrahim, H. (2023). Toxoplasmosis in adult patients with haematologic malignancy: Seroprevalence of anti-Toxoplasma antibodies and molecular diagnosis. EKB Journal Management System, 16(1), 79-86. doi: 10.21608/puj.2023.203903.1209
Taha Shaw; Hend El-Taweel; Maha Gammal; Safia Khali; Heba Ibrahim. "Toxoplasmosis in adult patients with haematologic malignancy: Seroprevalence of anti-Toxoplasma antibodies and molecular diagnosis". EKB Journal Management System, 16, 1, 2023, 79-86. doi: 10.21608/puj.2023.203903.1209
Shaw, T., El-Taweel, H., Gammal, M., Khali, S., Ibrahim, H. (2023). 'Toxoplasmosis in adult patients with haematologic malignancy: Seroprevalence of anti-Toxoplasma antibodies and molecular diagnosis', EKB Journal Management System, 16(1), pp. 79-86. doi: 10.21608/puj.2023.203903.1209
Shaw, T., El-Taweel, H., Gammal, M., Khali, S., Ibrahim, H. Toxoplasmosis in adult patients with haematologic malignancy: Seroprevalence of anti-Toxoplasma antibodies and molecular diagnosis. EKB Journal Management System, 2023; 16(1): 79-86. doi: 10.21608/puj.2023.203903.1209

Toxoplasmosis in adult patients with haematologic malignancy: Seroprevalence of anti-Toxoplasma antibodies and molecular diagnosis

Parasitologists United Journal
Article 9, Volume 16, Issue 1, April 2023, Page 79-86  XML PDF (435.27 K)
Document Type: Original Article
DOI: 10.21608/puj.2023.203903.1209
View on SCiNiTO View on SCiNiTO
Authors
Taha Shaw1; Hend El-Taweel* 2; Maha Gammal3; Safia Khali4; Heba Ibrahimorcid 5
1Departments of Medical Laboratories , Faculty of Medicine and Health Science, Hodeidah University, Hodeidah, Yemen,
2Departments of Faculty of Medicine and Health Science, Hodeidah University, Hodeidah, Yemen, Medical Parasitology
3Departments of Haematology , Medical Research Institute, Alexandria University, Alexandria, Egypt
4Medical Parasitology , Medical Research Institute, Alexandria University, Alexandria, Egypt
5Medical Parasitology ,Medical Research Institute, Alexandria University, Alexandria, Egypt
Abstract
Background: Serological diagnosis of toxoplasmosis in patients with haematological malignancy (HM) is
challenged by the impaired antibody response; meanwhile, molecular testing is necessary to demonstrate
reactivation.
Objective: Study of detection rates and risk factors for toxoplasmosis in HM patients using serological and
molecular methods.
Subjects and Methods: The study included 40 adult patients with HM, and 40 age and sex-matched healthy
individuals. Data on risk factors of toxoplasmosis were collected. Serologic testing for anti-Toxoplasma IgG
and IgM antibodies was performed using ELISA. Blood samples were examined molecularly for detection
of T. gondii 529re gene.
Results: Seropositive rate was significantly (P=0.003) higher among patients (75%) compared to healthy
individuals (42.5%). However, seropositive patients displayed lower anti-Toxoplasma IgG concentrations
compared to healthy individuals (P<0.05). Positive PCR results were obtained in 13 patients (32.5%) and
one healthy individual (2.5%) with a significant difference (P=0.0004). Seropositive patients showed
higher PCR positive rate (36.7%) compared to seropositive healthy individuals (5.9%) (P<0.05). No
statistically significant association was recorded between toxoplasmosis and the collected data for risk
factors.
Conclusion: Patients with HM are at high risk of toxoplasmosis and/or reactivation of latent infection. The
combination of serology and PCR is more accurate to reach a definite diagnosis. Follow-up is necessary to
prevent the development of life-threatening toxoplasmosis in these patients.
Keywords
Egypt; haematologic malignancy; immunosuppression; molecular diagnosis; seroprevalence; toxoplasmosis
Statistics
Article View: 250
PDF Download: 574